2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website
The figure above shows the overall detectability of the specified assay in a range of different mouse sample types. Detectability in each sample matrix is presented as the mean % of all samples included in the validation studies that could be measured above the limit of detection (LOD).
Dilution of samples may be necessary for some sample matrices other than plasma or serum to achieve optimal assay performance – the data shown above represents the values obtained at the optimal dilution identified in each case. Details regarding possible dilutions should be discussed with your Olink representative prior to commencing the study. The data is compiled from multiple studies comprising a range of healthy and disease samples, including samples from genetically modified mouse lines in some cases.
(Note: CSF = cerebrospinal fluid; BAL = bronchoalveolar lavage).
Precision (repeatability) is calculated from linearized NPX values over LOD.
Additional validation data, as well as a more detailed description of how the Olink panels are quality controlled can be found in our Data Validation documents – go to Document download center
2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website